Showing posts with label Genome Editing in Humans. Show all posts
Showing posts with label Genome Editing in Humans. Show all posts

Thursday, August 8, 2024

Genome Editing in Humans ( APA styled)

 

 

 “If any of your loved ones is suffering from a genetic disorder like AIDS, Sickle cell Anemia, or Hemophilia. Doctors and scientists are positive about the cure of such diseases through Genome Editing, but they are helpless due to the ban on genome editing in Humans.” How would you feel?

 Introduction

Due to the advancements in science and technology, we have achieved marvels in every field. Let's take an example of genetic mutation, in the field of Agriculture we are now able to grow unseasoned vegetables and fruits. Have achieved good breeds in Animals. However, this technique is banned from even treating the lifelong diseases that pass on through generation to generation. Genome editing, particularly through techniques like CRISPR-Cas9, modifies the DNA (Deoxy Ribo nuclic Acid ) sequences in an organism . This is done to the disease-carrying genes, and transform it .This has completely revolutionized molecular biology. However, alongside its potential benefits, genome editing raises ethical, safety, and social concerns.

 

Genome Editing

Research in Genome Editing might do Wonders.

Genome editing in humans can treat and cure many genetic illnesses. Genome editing is a tool that needs further genomic editing of nucleases. Porteus, M. (2016). In Humans Genome editing enables researchers to edit the target section of DNA sequence. De Lecuona, I., Casado, M., Marfany, G., Baroni, M. L., & Escarrabill, M. (2017).Clinical trials have already shown promising results, indicating that gene editing can effectively treat certain diseases (Ledford, 2015).


Genome Editing might be risky.

Despite the positive outcome of genome editing in humans. we need to address why people on a large scale are against it. One of the main reasons is if it goes wrong then we will have to bear long-term consequences. For instance, Elephant babies, apes like humans, and Dogman. Despite its precision, genome editing is not without risks. Off-target effects, where unintended parts of the genome are altered, could potentially lead to harmful mutations (Zhang, 2019).

Genome Editing is morally unacceptable

As we know that most of the world population lives in a poverty stricken or war-torn areas, who could not enjoy the benefits of this advancement. They might become the guinea pigs of the scientists and wealthy people might fester on them. So this is morally unacceptable as this would be disproportionate and create fissures in the communities. Genome editing in humans might result in unintended harm the basic question is whether this should be done without compromising the self-esteem of any individual or nation. Hynes, R. O., Coller, B. S., & Porteus, M. (2017).

The long-term effects of genome editing are also unknown, raising concerns about unforeseen consequences for individuals and future generations.

Conclusion

 There should not be a ban on research, especially when it is done in good faith, to treat fatal and life-long diseases. Governments should provide funds to support the researchers. If through genome editing we excelled in Horticulture and Agriculture then why not this can be used to treat the genetic disorders in humans. I believe that research cannot be stopped ,this must be happening in the labs of many scientists secretively. However utmostcare and ethical risks should not be overlooked.


genome editing is done on the targetted gene


## References

De Lecuona, I., Casado, M., Marfany, G., Baroni, M. L., & Escarrabill, M. (2017). Focus: genome editing: gene editing in humans: towards a global and inclusive debate for responsible research. The Yale Journal of Biology and Medicine90(4), 673.

Hynes, R. O., Coller, B. S., & Porteus, M. (2017). Toward responsible human genome editing. Jama317(18), 1829-1830.

Ledford, H. (2015). CRISPR, the disruptor. Nature, 522(7554), 20-24.

Porteus, M. (2016). Genome editing: a new approach to human therapeutics. Annual review of pharmacology and toxicology56(1), 163-190.

Zhang, Y. (2019). Ethical issues in genome editing using CRISPR/Cas9 system. Journal of Clinical Research & Bioethics, 10(1), 1000344

RECENT

The courage to be disliked, in readers eyes

 " The Courage to Be Disliked " About the Authors Ichiro Kishimi , an Adlerian psychologist, and Fumitake Koga , a writer and phil...